Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",A1BG,Alpha-1B-glycoprotein,16059,90,5.03 [1.49-16.95],0.0092120471749794
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,18463,101,0.64 [0.43-0.93],0.0211463834523578
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",ACTA2,"Actin, aortic smooth muscle",18135,96,1.57 [1.16-2.13],0.0037718900686117
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",ACVRL1,Serine/threonine-protein kinase receptor R3,18278,99,2.10 [1.10-3.99],0.0236263853263609
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",ADA2,Adenosine deaminase 2,18378,97,2.25 [1.57-3.24],1.1647901550083388e-05
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,15553,86,2.04 [1.25-3.31],0.0040502271902811
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,18600,104,3.22 [2.12-4.89],3.9932587482532914e-08
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,15981,89,3.17 [1.87-5.39],2.0000477234027624e-05
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",ADGRE1,Adhesion G protein-coupled receptor E1,15981,89,2.03 [1.45-2.83],3.155842216858668e-05
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",ADGRE2,Adhesion G protein-coupled receptor E2,18524,102,2.67 [1.53-4.67],0.0005733794562456
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",ADGRE5,Adhesion G protein-coupled receptor E5,18602,101,2.29 [1.56-3.37],2.287160615987945e-05
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",AGR2,Anterior gradient protein 2 homolog,17936,98,1.24 [1.04-1.48],0.0194678645027313
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",AGRN,Agrin,18524,102,1.83 [1.16-2.91],0.0101174078229212
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,15035,86,1.44 [1.05-1.97],0.0241429674339518
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",ANXA2,Annexin A2,15363,85,1.35 [1.05-1.72],0.0171226512124646
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,18373,100,1.39 [1.00-1.92],0.0470763007416825
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",ARHGAP5,Rho GTPase-activating protein 5,15476,83,0.70 [0.50-0.99],0.0411385849254928
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",ARTN,Artemin,18156,100,1.34 [1.01-1.77],0.041770087017234
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",ATRAID,All-trans retinoic acid-induced differentiation factor,15981,89,1.74 [1.16-2.62],0.007801019386112
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",B2M,Beta-2-microglobulin,16059,90,1.73 [1.36-2.19],6.7728190468878985e-06
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",B4GALT1,"Beta-1,4-galactosyltransferase 1",18524,102,3.07 [1.70-5.53],0.0001996150136301
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",BAMBI,BMP and activin membrane-bound inhibitor homolog,18045,99,2.59 [1.60-4.20],0.0001044952312969
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",BAP18,Chromatin complexes subunit BAP18,16004,88,1.26 [1.00-1.59],0.0485642944626356
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",BCL2,Apoptosis regulator Bcl-2,15981,89,1.77 [1.46-2.16],8.501118866617686e-09
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",BGN,Biglycan,18019,99,1.19 [1.03-1.37],0.0216472576308928
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",BID,BH3-interacting domain death agonist,18457,101,0.72 [0.54-0.96],0.0239194910349486
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",BLNK,B-cell linker protein,15553,86,1.82 [1.27-2.62],0.0010869021157313
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",BRK1,Protein BRICK1,18068,99,1.71 [1.19-2.47],0.0037062426685179
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,18630,104,1.72 [1.04-2.84],0.0357521664547968
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",BTN2A1,Butyrophilin subfamily 2 member A1,18524,102,2.50 [1.39-4.47],0.0021176116161622
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",BTN3A2,Butyrophilin subfamily 3 member A2,18457,101,1.92 [1.29-2.84],0.0012145255070116
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",C1QA,Complement C1q subcomponent subunit A,18594,103,4.58 [2.55-8.22],3.7137011728093523e-07
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",C1RL,Complement C1r subcomponent-like protein,16024,90,4.71 [1.66-13.40],0.003654893357466
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",C1S,Complement C1s subcomponent,16059,90,2.41 [1.00-5.80],0.0493273700039222
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",C9,Complement component C9,16055,90,1.53 [1.06-2.21],0.0221793055855857
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",CA8,Carbonic anhydrase-related protein,15553,86,1.69 [1.00-2.86],0.0498422122687976
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",CAMLG,Guided entry of tail-anchored proteins factor CAMLG,15620,81,0.47 [0.28-0.79],0.0042292649116783
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,16010,87,0.81 [0.66-0.99],0.0371676510534094
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",CANT1,Soluble calcium-activated nucleotidase 1,18400,101,2.77 [1.17-6.56],0.0206155043890957
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",CBLN4,Cerebellin-4,18638,102,0.56 [0.33-0.97],0.0390883385947541
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",CCL14,C-C motif chemokine 14,18436,98,1.53 [1.05-2.24],0.0272129421295898
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",CCL21,C-C motif chemokine 21,18524,102,1.64 [1.16-2.31],0.0047530643288049
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",CCL24,C-C motif chemokine 24,18503,102,1.29 [1.05-1.59],0.0147402351280758
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",CCL3,C-C motif chemokine 3,18457,101,1.33 [1.10-1.61],0.0029388563425946
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",CCL4,C-C motif chemokine 4,18465,101,1.29 [1.05-1.58],0.0136486875142889
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",CD160,CD160 antigen,18685,103,1.79 [1.28-2.50],0.0006540267109702
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",CD1C,T-cell surface glycoprotein CD1c,18507,102,2.28 [1.10-4.72],0.0258067730962759
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",CD200,OX-2 membrane glycoprotein,18457,101,2.30 [1.33-3.99],0.0029925339327714
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",CD209,CD209 antigen,18512,102,0.52 [0.33-0.83],0.0064119492445821
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",CD22,B-cell receptor CD22,18685,103,2.61 [1.94-3.52],2.1939937807398048e-10
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",CD27,CD27 antigen,18507,102,3.48 [2.51-4.82],6.20202479518261e-14
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",CD274,Programmed cell death 1 ligand 1,18313,100,1.77 [1.11-2.83],0.0166669959288184
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",CD28,T-cell-specific surface glycoprotein CD28,18045,99,2.26 [1.79-2.84],4.01711224244313e-12
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",CD300A,CMRF35-like molecule 8,15684,89,2.83 [1.55-5.16],0.0007042595333663
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",CD300C,CMRF35-like molecule 6,18630,104,2.47 [1.56-3.92],0.00012090038723
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",CD300E,CMRF35-like molecule 2,18584,102,2.72 [1.91-3.88],3.066245894312976e-08
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",CD300LF,CMRF35-like molecule 1,18638,102,1.53 [1.10-2.13],0.0106018366327886
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",CD4,T-cell surface glycoprotein CD4,18425,101,1.71 [1.13-2.61],0.0116736905113007
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",CD48,CD48 antigen,18503,102,3.47 [2.01-6.00],7.93478508646913e-06
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",CD5,T-cell surface glycoprotein CD5,18612,102,3.25 [2.46-4.30],1.8283204423731287e-16
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",CD59,CD59 glycoprotein,17821,96,2.33 [1.21-4.49],0.0113512436567239
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",CD5L,CD5 antigen-like,15989,88,1.91 [1.27-2.90],0.002115462770857
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",CD6,T-cell differentiation antigen CD6,18652,103,1.94 [1.39-2.71],0.0001039879921931
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",CD7,T-cell antigen CD7,15526,86,2.05 [1.44-2.92],7.452537813304488e-05
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",CD70,CD70 antigen,18457,101,3.43 [2.53-4.65],1.7521819530702362e-15
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",CD72,B-cell differentiation antigen CD72,15684,89,5.06 [3.44-7.44],1.8586644528215807e-16
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",CD74,HLA class II histocompatibility antigen gamma chain,18630,104,3.75 [2.45-5.73],9.84311918387174e-10
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",CD79B,B-cell antigen receptor complex-associated protein beta chain,18685,103,3.63 [2.84-4.65],1.3733952597190214e-24
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",CD80,T-lymphocyte activation antigen CD80,16035,90,4.77 [3.27-6.95],4.119440375157971e-16
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",CD82,CD82 antigen,15752,83,0.37 [0.18-0.76],0.0073595977342909
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",CD83,CD83 antigen,18457,101,3.52 [2.27-5.47],2.1628032649644506e-08
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",CD86,T-lymphocyte activation antigen CD86,15981,89,3.13 [1.72-5.70],0.0001920480109805
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",CDC123,Cell division cycle protein 123 homolog,15476,83,1.33 [1.05-1.69],0.0188177759147669
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",CDCP1,CUB domain-containing protein 1,18313,100,1.46 [1.09-1.95],0.0102316305756429
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",CDH3,Cadherin-3,18630,104,2.25 [1.46-3.47],0.0002345167574519
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",CDHR5,Cadherin-related family member 5,18463,101,0.64 [0.42-0.97],0.0369969120822811
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",CDK5RAP3,CDK5 regulatory subunit-associated protein 3,16010,87,0.66 [0.44-0.99],0.0428663666407895
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,15981,89,1.84 [1.20-2.82],0.0055496690838618
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,18457,101,1.22 [1.01-1.48],0.0416141463459069
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",CEP152,Centrosomal protein of 152 kDa,15476,83,0.55 [0.31-0.98],0.0433232518702307
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",CES3,Carboxylesterase 3,18373,100,0.60 [0.44-0.82],0.0013970434544819
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",CFHR2,Complement factor H-related protein 2,15945,90,1.85 [1.21-2.83],0.0045551387420515
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",CFHR4,Complement factor H-related protein 4,16025,90,1.38 [1.02-1.86],0.0365961440123825
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",CFHR5,Complement factor H-related protein 5,15854,87,1.76 [1.04-2.97],0.0350366131961783
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",CGA,Glycoprotein hormones alpha chain,18464,102,1.60 [1.26-2.03],0.0001105419352284
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",16004,88,1.72 [1.19-2.48],0.0037963370062967
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",CHCHD6,MICOS complex subunit MIC25,15978,90,1.78 [1.01-3.15],0.0454241516693133
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",CHEK2,Serine/threonine-protein kinase Chk2,18135,96,0.50 [0.29-0.89],0.017579391955221
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",CHGA,Chromogranin-A,16044,90,1.30 [1.08-1.57],0.0048711752050307
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",CHI3L1,Chitinase-3-like protein 1,18085,96,1.27 [1.04-1.55],0.0184387931143861
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",CHRDL1,Chordin-like protein 1,18503,102,1.74 [1.02-2.97],0.0409259116906061
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",CIT,Citron Rho-interacting kinase,15620,81,1.48 [1.03-2.13],0.0337265701853631
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",CKAP4,Cytoskeleton-associated protein 4,18593,102,2.40 [1.61-3.59],1.8740127716459296e-05
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",CKB,Creatine kinase B-type,16044,90,1.48 [1.05-2.09],0.0254365548018323
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",CLEC12A,C-type lectin domain family 12 member A,15553,86,2.91 [1.68-5.02],0.0001279374174323
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",CLEC4M,C-type lectin domain family 4 member M,16022,90,0.65 [0.43-0.99],0.0456988574200747
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",CLEC6A,C-type lectin domain family 6 member A,18045,99,1.94 [1.40-2.70],6.896275742779119e-05
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",CLEC7A,C-type lectin domain family 7 member A,18685,103,1.89 [1.29-2.76],0.0011496445821255
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",CLSTN3,Calsyntenin-3,16004,88,2.09 [1.18-3.70],0.0115451382095952
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",COCH,Cochlin,16035,90,1.60 [1.06-2.41],0.0242281296964389
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",COL4A1,Collagen alpha-1(IV) chain,18463,101,1.91 [1.27-2.87],0.0019379127714394
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",COL6A3,Collagen alpha-3(VI) chain,18693,102,2.13 [1.39-3.26],0.0005364293036692
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",COLEC12,Collectin-12,18434,102,2.28 [1.24-4.21],0.008314815714323
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",CR2,Complement receptor type 2,18552,101,1.61 [1.11-2.33],0.0112325180226167
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",CRTAC1,Cartilage acidic protein 1,18693,102,0.56 [0.33-0.96],0.035020635379138
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",CRTAM,Cytotoxic and regulatory T-cell molecule,18313,100,3.83 [2.82-5.20],5.8871961160653794e-18
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",CSF1,Macrophage colony-stimulating factor 1,18524,102,2.95 [1.62-5.39],0.0004200685858471
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,18313,100,1.35 [1.05-1.75],0.0203520155195117
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",CSF3R,Granulocyte colony-stimulating factor receptor,15553,86,2.17 [1.36-3.47],0.0012035918411476
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",CST3,Cystatin-C,18517,101,2.08 [1.19-3.64],0.0100849452665404
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",CSTB,Cystatin-B,18208,96,1.62 [1.11-2.36],0.0132938121659695
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",CTSB,Cathepsin B,18469,101,1.40 [1.02-1.92],0.0357111564458819
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",CTSH,Pro-cathepsin H,18072,95,1.36 [1.07-1.73],0.0112583468368714
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",CTSL,Cathepsin L1,18463,101,3.66 [1.94-6.90],6.355970601270005e-05
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",CTSO,Cathepsin O,18685,103,2.04 [1.23-3.39],0.0060715405220346
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",CTSV,Cathepsin L2,18569,102,0.62 [0.39-0.99],0.044840771882229
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",CXCL10,C-X-C motif chemokine 10,18524,102,1.54 [1.24-1.90],7.364658183693923e-05
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",CXCL11,C-X-C motif chemokine 11,18630,104,1.26 [1.04-1.51],0.0154236714912619
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",CXCL13,C-X-C motif chemokine 13,18630,104,0.42 [0.26-0.69],0.0004832917113043
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",CXCL17,C-X-C motif chemokine 17,18685,103,1.48 [1.02-2.16],0.0401778311994763
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",CXCL9,C-X-C motif chemokine 9,18524,102,1.90 [1.60-2.26],4.318991606150939e-13
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",DCTPP1,dCTP pyrophosphatase 1,18463,101,3.40 [2.10-5.52],7.187492674847345e-07
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",DCUN1D2,DCN1-like protein 2,15476,83,0.63 [0.45-0.89],0.0096322996259316
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",DEFA1_DEFA1B,Neutrophil defensin 1,18120,100,1.33 [1.00-1.77],0.0461825883896692
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",DGKZ,Diacylglycerol kinase zeta,18156,100,0.55 [0.32-0.92],0.0235154613148571
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",DHPS,Deoxyhypusine synthase,15978,90,1.70 [1.23-2.34],0.0013211499313036
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",DLL1,Delta-like protein 1,18507,102,2.45 [1.44-4.17],0.0009612364071434
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",DPEP2,Dipeptidase 2,18373,100,2.11 [1.22-3.64],0.0072615353937732
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",DSC2,Desmocollin-2,18235,102,1.93 [1.20-3.10],0.0067729499331513
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",DTX3,Probable E3 ubiquitin-protein ligase DTX3,18373,100,2.68 [1.46-4.91],0.0014779222615286
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",EBI3_IL27,Interleukin-27,18615,102,3.34 [1.96-5.70],9.94616662295478e-06
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",EDA2R,Tumor necrosis factor receptor superfamily member 27,18638,102,1.95 [1.28-2.95],0.001793373188736
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,18135,96,0.57 [0.33-1.00],0.0495408913018182
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",EDN1,Endothelin-1,15587,86,2.04 [1.04-4.01],0.0379641057883641
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",EFCAB14,EF-hand calcium-binding domain-containing protein 14,15981,89,1.77 [1.19-2.63],0.0051133570740052
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",EFNA4,Ephrin-A4,18278,99,3.55 [2.32-5.45],6.017358315995903e-09
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,16010,87,0.66 [0.47-0.94],0.0205693480437239
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",ENO3,Beta-enolase,15587,86,0.63 [0.42-0.92],0.0176825416915293
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,18693,102,2.15 [1.09-4.26],0.0276584094899112
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",EPHA2,Ephrin type-A receptor 2,17818,97,1.99 [1.18-3.33],0.0094259825262915
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",EPHB4,Ephrin type-B receptor 4,18693,102,2.13 [1.12-4.04],0.0207793476944416
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",EPHB6,Ephrin type-B receptor 6,18285,100,1.80 [1.06-3.07],0.0307855129280429
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",EPO,Erythropoietin,18457,101,1.40 [1.16-1.68],0.0004119518026418
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",ERP44,Endoplasmic reticulum resident protein 44,18347,100,0.48 [0.24-0.97],0.0410083512888436
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",EZR,Ezrin,18630,104,3.05 [1.72-5.42],0.0001369573852816
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",FABP1,"Fatty acid-binding protein, liver",18434,102,1.21 [1.01-1.44],0.0353064085192021
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",FABP4,"Fatty acid-binding protein, adipocyte",18693,102,1.53 [1.10-2.13],0.0111980190487181
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",FAM3C,Protein FAM3C,18442,100,1.77 [1.00-3.11],0.0490796545175683
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,16035,90,2.14 [1.65-2.77],8.624313429565992e-09
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",FCER2,Low affinity immunoglobulin epsilon Fc receptor,18464,102,2.17 [1.68-2.79],1.7744465879480343e-09
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",FCRL1,Fc receptor-like protein 1,18463,101,2.23 [1.60-3.11],2.5184734896580586e-06
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",FCRL2,Fc receptor-like protein 2,18599,101,2.86 [2.32-3.51],2.4323968265599608e-23
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",FCRL3,Fc receptor-like protein 3,18156,100,2.25 [1.71-2.97],8.716765077242669e-09
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",FCRL5,Fc receptor-like protein 5,18464,102,1.53 [1.13-2.06],0.0053858981190511
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",FCRLB,Fc receptor-like B,18045,99,1.43 [1.16-1.75],0.0007246840334781
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",FGA,Fibrinogen alpha chain,15693,88,2.33 [1.24-4.39],0.0086301403941291
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",FGL1,Fibrinogen-like protein 1,16055,90,1.42 [1.04-1.93],0.0265926486379352
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",FHIP2A,FHF complex subunit HOOK interacting protein 2A,15510,86,1.49 [1.10-2.01],0.0099274982465155
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",FLRT2,Leucine-rich repeat transmembrane protein FLRT2,18313,100,1.88 [1.05-3.39],0.0345846493366752
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",FLT3LG,Fms-related tyrosine kinase 3 ligand,18685,103,1.68 [1.02-2.76],0.0407668984040069
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",FRMD4B,FERM domain-containing protein 4B,15510,86,0.70 [0.50-0.97],0.0323995346045233
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",FSHB,Follitropin subunit beta,15587,86,1.71 [1.33-2.20],2.531275588514157e-05
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",FSTL1,Follistatin-related protein 1,15587,86,2.59 [1.07-6.24],0.0341500440984244
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",FSTL3,Follistatin-related protein 3,18404,102,2.04 [1.24-3.34],0.0050246201653401
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,18156,100,1.60 [1.10-2.32],0.013498473942783
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",GAST,Gastrin,16004,88,1.17 [1.02-1.33],0.0198934170512868
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",GBP1,Guanylate-binding protein 1,15976,88,1.69 [1.30-2.21],0.0001151835552601
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",GBP2,Guanylate-binding protein 2,18156,100,1.44 [1.13-1.83],0.0027903139341467
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,15305,84,1.45 [1.03-2.04],0.0323366590193365
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",18373,100,3.28 [2.07-5.18],3.977277291417346e-07
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",GDF15,Growth/differentiation factor 15,18693,102,1.69 [1.22-2.34],0.0015455310293875
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",GDF2,Growth/differentiation factor 2,18463,101,0.51 [0.31-0.85],0.0093701818680543
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",GFRA1,GDNF family receptor alpha-1,18615,102,2.26 [1.28-4.00],0.0048935953078542
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",GGA1,ADP-ribosylation factor-binding protein GGA1,18068,99,0.70 [0.50-0.99],0.0438531741459859
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",GIMAP7,GTPase IMAP family member 7,15684,89,1.94 [1.27-2.95],0.0020667057692522
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",GIPC2,PDZ domain-containing protein GIPC2,16004,88,2.54 [1.55-4.18],0.0002205451571515
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",GPC1,Glypican-1,18638,102,0.42 [0.23-0.76],0.004044791209736
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",GRN,Progranulin,18364,101,2.50 [1.27-4.91],0.0080832851613772
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",GZMA,Granzyme A,18685,103,2.43 [1.64-3.61],9.412199032368864e-06
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",GZMH,Granzyme H,18135,96,1.32 [1.12-1.54],0.0007746732545725
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",HAVCR2,Hepatitis A virus cellular receptor 2,18464,102,1.91 [1.22-3.02],0.0050882530559443
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",HGFAC,Hepatocyte growth factor activator,15913,88,0.46 [0.24-0.88],0.0188717959193763
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",18395,101,1.65 [1.05-2.61],0.0299382802733054
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",HLA-E,"HLA class I histocompatibility antigen, alpha chain E",18457,101,2.41 [1.48-3.93],0.0003981037065449
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",HMOX1,Heme oxygenase 1,18264,99,1.82 [1.31-2.52],0.0003613354195108
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",HNMT,Histamine N-methyltransferase,18228,99,1.62 [1.14-2.32],0.0078613273836587
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,16004,88,1.50 [1.09-2.06],0.0118697535349644
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",ICAM1,Intercellular adhesion molecule 1,18404,98,2.23 [1.26-3.96],0.0060554426845137
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",ICAM3,Intercellular adhesion molecule 3,18693,102,5.97 [3.48-10.25],9.01900644857184e-11
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",IDO1,"Indoleamine 2,3-dioxygenase 1",15587,86,1.56 [1.18-2.07],0.0016260471261976
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",IFI30,Gamma-interferon-inducible lysosomal thiol reductase,15614,84,3.05 [2.02-4.60],1.0263432277368821e-07
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",IFNGR1,Interferon gamma receptor 1,18524,102,2.50 [1.36-4.58],0.0030766457536305
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",IFNL1,Interferon lambda-1,18068,99,1.48 [1.04-2.11],0.0285884853644584
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",IFNLR1,Interferon lambda receptor 1,18457,101,1.88 [1.35-2.62],0.0001973388374423
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",IGFBP2,Insulin-like growth factor-binding protein 2,18663,102,1.48 [1.11-1.98],0.008389547874053
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",IGFBP4,Insulin-like growth factor-binding protein 4,18240,101,1.50 [1.05-2.13],0.0259152912561191
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",IGFBP7,Insulin-like growth factor-binding protein 7,18693,102,1.66 [1.08-2.55],0.0201162214309524
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",IGLC2,Immunoglobulin lambda constant 2,16037,90,1.81 [1.21-2.72],0.0041937814729703
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",IGSF3,Immunoglobulin superfamily member 3,18373,100,1.68 [1.05-2.66],0.0289443051651683
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",IL10,Interleukin-10,18156,100,1.44 [1.23-1.68],4.7940441355807324e-06
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",IL10RB,Interleukin-10 receptor subunit beta,18524,102,1.95 [1.25-3.02],0.002948767469249
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",IL12A_IL12B,Interleukin-12,18373,100,1.94 [1.60-2.37],4.5416944790259706e-11
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",IL12B,Interleukin-12 subunit beta,18685,103,2.80 [2.08-3.77],1.1165652624018152e-11
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",IL12RB1,Interleukin-12 receptor subunit beta-1,18156,100,2.03 [1.32-3.10],0.0011535741166576
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",IL15RA,Interleukin-15 receptor subunit alpha,18156,100,1.98 [1.21-3.25],0.0065973678655729
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",IL16,Pro-interleukin-16,18685,103,1.49 [1.06-2.09],0.0223553680975788
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",IL18,Interleukin-18,18370,101,2.00 [1.42-2.83],7.445537178061147e-05
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",IL18BP,Interleukin-18-binding protein,18552,101,2.79 [1.71-4.55],3.685944264517785e-05
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",IL18R1,Interleukin-18 receptor 1,18685,103,2.25 [1.36-3.74],0.0016616310116073
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",IL19,Interleukin-19,18001,100,1.26 [1.01-1.57],0.0367870131932507
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",IL1RL1,Interleukin-1 receptor-like 1,18632,101,1.56 [1.07-2.29],0.0223909227101917
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",IL20RA,Interleukin-20 receptor subunit alpha,18156,100,1.34 [1.01-1.78],0.0410840733279131
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",IL2RA,Interleukin-2 receptor subunit alpha,18346,100,3.49 [2.65-4.62],1.1820790653612953e-18
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",IL32,Interleukin-32,18457,101,1.87 [1.39-2.52],3.943909946775084e-05
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",IL4R,Interleukin-4 receptor subunit alpha,18457,101,1.71 [1.09-2.69],0.0207002534012225
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",IL6,Interleukin-6,18373,100,1.40 [1.19-1.66],5.896446269862058e-05
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",ITGA11,Integrin alpha-11,18457,101,0.55 [0.33-0.92],0.0217638847305961
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",ITGA2,Integrin alpha-2,15684,89,0.53 [0.30-0.96],0.0355522130925999
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",ITGAL,Integrin alpha-L,15553,86,2.43 [1.46-4.04],0.00062892677096
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",ITGB2,Integrin beta-2,18371,98,1.93 [1.09-3.43],0.0241139098648274
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",JAM2,Junctional adhesion molecule B,18630,104,1.92 [1.06-3.48],0.0314472225375773
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",KCTD5,BTB/POZ domain-containing protein KCTD5,15685,83,1.72 [1.28-2.29],0.0002672493864715
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",KIAA0319,Dyslexia-associated protein KIAA0319,16004,88,1.88 [1.19-2.97],0.0072032873853834
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,18045,99,0.79 [0.68-0.91],0.0014045404474223
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",KIT,Mast/stem cell growth factor receptor Kit,18529,100,0.54 [0.30-0.98],0.0422291493660933
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",KLK11,Kallikrein-11,18323,102,1.56 [1.05-2.34],0.0294832046545123
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",KLK13,Kallikrein-13,18034,98,1.50 [1.03-2.19],0.0355513888222661
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",KLK15,Kallikrein-15,15947,90,1.83 [1.26-2.66],0.0015982613640715
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",KLK4,Kallikrein-4,18638,102,1.50 [1.20-1.87],0.0003872764008425
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",KLRB1,Killer cell lectin-like receptor subfamily B member 1,18685,103,1.80 [1.17-2.77],0.0073220809102826
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",KLRD1,Natural killer cells antigen CD94,18685,103,1.86 [1.30-2.67],0.0007468715381472
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",KLRK1,NKG2-D type II integral membrane protein,16004,88,1.87 [1.40-2.49],2.2737666219194337e-05
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",LAG3,Lymphocyte activation gene 3 protein,18373,100,2.05 [1.50-2.80],5.943918617790601e-06
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,18434,102,2.45 [1.77-3.38],5.179247525243152e-08
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,18313,100,1.20 [1.00-1.44],0.0457600727963938
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",LAYN,Layilin,18285,100,1.80 [1.15-2.83],0.0108043637845745
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",LGALS9,Galectin-9,18444,101,4.10 [2.55-6.58],5.083621377533815e-09
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,18464,102,1.80 [1.07-3.01],0.025814961827784
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,18442,100,2.18 [1.28-3.69],0.0038803644598966
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,18693,102,3.74 [2.02-6.94],2.7907632488474578e-05
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,18602,101,2.25 [1.32-3.86],0.0031070565347602
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,18156,100,2.18 [1.51-3.15],3.3208883205597346e-05
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",LMNB2,Lamin-B2,16004,88,2.84 [1.73-4.68],4.061024151246828e-05
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",LPO,Lactoperoxidase,17817,95,1.40 [1.04-1.87],0.0264928225488579
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",LRG1,Leucine-rich alpha-2-glycoprotein,16059,90,4.65 [2.35-9.18],9.959698483376877e-06
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,18589,102,2.30 [1.46-3.61],0.0003296163633054
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",LRRC25,Leucine-rich repeat-containing protein 25,18373,100,1.63 [1.17-2.28],0.0039339857870555
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",LRRC37A2,Leucine-rich repeat-containing protein 37A2,15981,89,1.88 [1.18-2.98],0.007461699356659
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",LRRN1,Leucine-rich repeat neuronal protein 1,18156,100,0.52 [0.34-0.80],0.0031600172291269
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,15620,81,1.56 [1.14-2.15],0.0060124037085518
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",LSP1,Lymphocyte-specific protein 1,18457,101,1.59 [1.05-2.40],0.0274595253324681
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",LTA,Lymphotoxin-alpha,18457,101,2.33 [1.74-3.11],1.2256057488532444e-08
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",LTA4H,Leukotriene A-4 hydrolase,18638,102,1.33 [1.01-1.74],0.0397619245414697
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",LTBP2,Latent-transforming growth factor beta-binding protein 2,18693,102,1.95 [1.15-3.33],0.0139244932093087
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",LTBR,Tumor necrosis factor receptor superfamily member 3,18341,101,2.51 [1.50-4.20],0.0004515234734823
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",LUZP2,Leucine zipper protein 2,15978,90,1.51 [1.05-2.17],0.0265356055089573
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",LY6D,Lymphocyte antigen 6D,18347,101,2.28 [1.63-3.19],1.6546800667238794e-06
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",LY9,T-lymphocyte surface antigen Ly-9,18235,101,6.42 [3.95-10.42],5.34769473822422e-14
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",LYZL2,Lysozyme-like protein 2,15476,83,0.36 [0.18-0.71],0.0032064339135455
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",15587,86,2.59 [1.14-5.88],0.0231763839835304
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",MARCO,Macrophage receptor MARCO,18463,101,2.78 [1.39-5.56],0.003712546313645
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",MIA,Melanoma-derived growth regulatory protein,18507,102,1.77 [1.16-2.69],0.00770354093605
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",MILR1,Allergin-1,18156,100,1.44 [1.03-2.00],0.0319157607291006
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",MLN,Promotilin,18457,101,1.29 [1.05-1.58],0.013392615107689
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",MMP15,Matrix metalloproteinase-15,16035,90,1.35 [1.02-1.79],0.0384604123785173
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",MMUT,"Methylmalonyl-CoA mutase, mitochondrial",15510,86,0.62 [0.39-0.99],0.0443283949001572
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",MRC1,Macrophage mannose receptor 1,16055,90,1.99 [1.00-3.94],0.0485277917296999
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",MSR1,Macrophage scavenger receptor types I and II,18630,104,1.47 [1.00-2.14],0.0471058053458929
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",MYOM1,Myomesin-1,15546,84,1.37 [1.01-1.86],0.0414498209947197
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",NAAA,N-acylethanolamine-hydrolyzing acid amidase,18233,100,1.36 [1.03-1.78],0.0290222278311873
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,15981,89,2.08 [1.23-3.52],0.0066309773778171
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",18045,99,1.21 [1.01-1.43],0.0349007139649384
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",NECTIN4,Nectin-4,18507,102,1.77 [1.10-2.87],0.0198219207304541
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",NEFL,Neurofilament light polypeptide,18016,99,1.54 [1.11-2.13],0.0099902847798098
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",NEK7,Serine/threonine-protein kinase Nek7,15752,83,0.59 [0.40-0.87],0.007255723194992
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",NELL1,Protein kinase C-binding protein NELL1,18507,102,0.57 [0.38-0.87],0.0082689089225984
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",NME1,Nucleoside diphosphate kinase A,15553,86,3.06 [1.61-5.83],0.0006491082792014
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",NOS1,"Nitric oxide synthase, brain",18068,99,1.49 [1.14-1.96],0.003891902463114
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",NOS3,"Nitric oxide synthase, endothelial",18068,99,1.99 [1.71-2.33],1.845634387481549e-18
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",NOTCH1,Neurogenic locus notch homolog protein 1,18693,102,3.05 [1.04-8.96],0.0422377371681301
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",NOTCH3,Neurogenic locus notch homolog protein 3,18693,102,1.87 [1.12-3.13],0.017019781000108
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",NPC2,NPC intracellular cholesterol transporter 2,15779,86,2.17 [1.25-3.77],0.0058862546193786
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",NPDC1,Neural proliferation differentiation and control protein 1,18463,101,2.11 [1.36-3.26],0.0008390077901463
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",NPPB,Natriuretic peptides B,18135,96,1.19 [1.05-1.36],0.0078134649675209
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",NPPC,C-type natriuretic peptide,18457,101,1.40 [1.03-1.91],0.0316640374885644
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",NRCAM,Neuronal cell adhesion molecule,18463,101,2.03 [1.12-3.66],0.0191475241630795
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",NRP2,Neuropilin-2,18464,102,1.88 [1.08-3.27],0.025289179989923
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",NRTN,Neurturin,18156,100,1.38 [1.04-1.84],0.0267736921197474
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",NTF4,Neurotrophin-4,18045,99,1.58 [1.18-2.11],0.0018458942264234
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",NTproBNP,N-terminal prohormone of brain natriuretic peptide,18463,101,1.30 [1.14-1.49],7.66726824745837e-05
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",OFD1,Oral-facial-digital syndrome 1 protein,15752,83,1.36 [1.07-1.71],0.0106873365737832
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",OGFR,Opioid growth factor receptor,18373,100,1.82 [1.08-3.06],0.0234807100738074
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",OGN,Mimecan,18464,102,1.53 [1.04-2.27],0.0321843494019909
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",ORM1,Alpha-1-acid glycoprotein 1,15998,90,5.52 [2.58-11.78],1.038429909409808e-05
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",OSBPL2,Oxysterol-binding protein-related protein 2,16004,88,1.50 [1.09-2.06],0.0126146567061524
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",OSCAR,Osteoclast-associated immunoglobulin-like receptor,18464,102,2.01 [1.21-3.34],0.0071522480256444
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",PAMR1,Inactive serine protease PAMR1,18464,102,0.50 [0.26-0.96],0.0378830663029316
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",PARP1,Poly [ADP-ribose] polymerase 1,18457,101,1.27 [1.01-1.59],0.0415177763105716
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",PDCD1,Programmed cell death protein 1,18606,102,5.20 [4.09-6.61],3.8679858504187557e-41
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",15476,83,0.53 [0.30-0.94],0.03101479415195
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",PDRG1,p53 and DNA damage-regulated protein 1,15620,81,0.55 [0.32-0.94],0.0290731810206094
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",PGA4,Pepsin A-4,16055,90,1.32 [1.02-1.71],0.0367887657005472
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",PGF,Placenta growth factor,18685,103,2.60 [1.63-4.14],5.815507323932799e-05
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",16010,87,0.76 [0.57-1.00],0.0476294644873577
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",PLA2G2A,"Phospholipase A2, membrane associated",18449,102,1.39 [1.08-1.80],0.0102834873188664
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",PLAT,Tissue-type plasminogen activator,18632,101,0.71 [0.51-0.99],0.0446445754256508
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",PLAUR,Urokinase plasminogen activator surface receptor,18319,100,3.46 [1.97-6.08],1.597860218905171e-05
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",PLTP,Phospholipid transfer protein,18635,102,1.67 [1.03-2.72],0.0378280070922559
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",PLXNB2,Plexin-B2,18609,101,2.30 [1.18-4.46],0.0138828991332367
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",PRELP,Prolargin,18434,102,2.16 [1.05-4.44],0.0363462772255289
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",PROC,Vitamin K-dependent protein C,18529,100,0.49 [0.25-0.98],0.0431093106253641
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",PRR4,Proline-rich protein 4,15574,89,1.37 [1.05-1.78],0.0201824281007762
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",PRTN3,Myeloblastin,18006,98,1.40 [1.04-1.88],0.0266133018468262
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",PSAP,Prosaposin,15903,87,2.62 [1.45-4.72],0.0014304686945751
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",PTGDS,Prostaglandin-H2 D-isomerase,18352,97,1.85 [1.13-3.02],0.0144491615594342
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",PTGR1,Prostaglandin reductase 1,16035,90,0.70 [0.55-0.90],0.0058313672387324
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",PTPRC,Receptor-type tyrosine-protein phosphatase C,16044,90,5.08 [2.76-9.35],1.7748654561474244e-07
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",PTPRH,Receptor-type tyrosine-protein phosphatase H,15981,89,1.63 [1.12-2.38],0.0116719646018756
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",PTPRS,Receptor-type tyrosine-protein phosphatase S,18693,102,2.42 [1.24-4.74],0.0097063157770415
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",PTX3,Pentraxin-related protein PTX3,18457,101,1.60 [1.05-2.43],0.027181277500889
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",PVALB,Parvalbumin alpha,18563,102,0.84 [0.73-0.97],0.0212232124285007
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",PYDC1,Pyrin domain-containing protein 1,15587,86,1.53 [1.04-2.26],0.0304288560285392
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",PZP,Pregnancy zone protein,16059,90,2.01 [1.23-3.29],0.0055106451456859
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",QPCT,Glutaminyl-peptide cyclotransferase,18476,100,1.95 [1.01-3.79],0.0475268491555952
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",QSOX1,Sulfhydryl oxidase 1,15737,87,1.40 [1.01-1.94],0.0435913247562306
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",RBFOX3,RNA binding protein fox-1 homolog 3,16010,87,1.61 [1.08-2.41],0.020759326826401
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",RBP5,Retinol-binding protein 5,18373,100,1.47 [1.09-1.99],0.0118171655908852
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",REG3A,Regenerating islet-derived protein 3-alpha,18693,102,1.46 [1.15-1.86],0.0018558448594406
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",RELT,Tumor necrosis factor receptor superfamily member 19L,18464,102,2.48 [1.50-4.13],0.0004443607218196
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",RET,Proto-oncogene tyrosine-protein kinase receptor Ret,18373,100,0.62 [0.39-0.99],0.0438039135269398
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",REXO2,"Oligoribonuclease, mitochondrial",15510,86,0.53 [0.29-0.96],0.0359122307830273
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",RGS8,Regulator of G-protein signaling 8,18156,100,1.25 [1.01-1.54],0.0366163415664883
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",RNASE6,Ribonuclease K6,15947,89,1.82 [1.31-2.54],0.0003841019565236
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",RNASET2,Ribonuclease T2,18607,101,2.49 [1.37-4.51],0.0026431749440496
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",RNF149,E3 ubiquitin-protein ligase RNF149,15587,86,3.40 [1.93-5.98],2.2894416756096208e-05
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",ROBO1,Roundabout homolog 1,18464,102,2.66 [1.34-5.28],0.005021045317501
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",RPL14,60S ribosomal protein L14,15587,86,1.63 [1.08-2.45],0.0189684436034465
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",RRM2,Ribonucleoside-diphosphate reductase subunit M2,18045,99,1.84 [1.50-2.24],2.536530569360481e-09
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",RSPO3,R-spondin-3,18638,102,1.85 [1.02-3.36],0.0425841225959079
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",S100A3,Protein S100-A3,15978,90,1.49 [1.18-1.88],0.0007743409697053
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",S100G,Protein S100-G,16010,87,1.46 [1.03-2.07],0.034735455064022
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",SART1,U4/U6.U5 tri-snRNP-associated protein 1,15510,86,1.54 [1.12-2.12],0.0082560460879962
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",SCARB2,Lysosome membrane protein 2,17961,98,2.52 [1.61-3.95],5.7213479204253226e-05
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",SCGB3A1,Secretoglobin family 3A member 1,15684,89,2.27 [1.06-4.87],0.0347003611637095
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",SDC1,Syndecan-1,18463,101,1.77 [1.19-2.64],0.0046075431633799
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",SDC4,Syndecan-4,18463,101,0.59 [0.41-0.85],0.0048846968904863
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",SEL1L,Protein sel-1 homolog 1,15587,86,1.52 [1.02-2.26],0.0375741544480211
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",SELL,L-selectin,16059,90,3.53 [1.58-7.88],0.0021455990209171
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",SELP,P-selectin,18552,101,0.68 [0.49-0.94],0.0196925904490662
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",SEMA4D,Semaphorin-4D,18630,104,1.95 [1.09-3.48],0.0247174443180039
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",SEMA7A,Semaphorin-7A,18632,101,5.03 [3.08-8.21],1.1650560143559148e-10
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",SEPTIN8,Septin-8,15972,88,1.77 [1.06-2.93],0.0275590027170641
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",SERPINA1,Alpha-1-antitrypsin,15763,87,8.13 [2.70-24.42],0.0001898901167885
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",SERPINA3,Alpha-1-antichymotrypsin,16015,89,3.08 [1.40-6.74],0.0050140160584796
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",SERPINA5,Plasma serine protease inhibitor,15822,88,0.41 [0.18-0.91],0.0277525058886025
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",SERPINA7,Thyroxine-binding globulin,16059,90,3.87 [1.44-10.40],0.0072311948404991
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",SERPINA9,Serpin A9,18295,100,1.36 [1.07-1.73],0.0118606346977326
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",SETMAR,Histone-lysine N-methyltransferase SETMAR,18244,98,1.80 [1.07-3.05],0.0278836774621669
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",SH2D1A,SH2 domain-containing protein 1A,18457,101,1.40 [1.12-1.75],0.0027977115482514
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",SHISA5,Protein shisa-5,16044,90,2.69 [1.57-4.61],0.0003007496971429
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",SIGLEC1,Sialoadhesin,18524,102,1.77 [1.18-2.64],0.0053598326188781
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",SIGLEC10,Sialic acid-binding Ig-like lectin 10,18457,101,4.95 [3.25-7.53],8.760824317528099e-14
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",SIGLEC6,Sialic acid-binding Ig-like lectin 6,18638,102,2.96 [1.85-4.74],6.002642953692351e-06
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",SIGLEC8,Sialic acid-binding Ig-like lectin 8,15587,86,1.82 [1.17-2.83],0.0083388598262089
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,18511,101,1.44 [1.02-2.03],0.0361498904247831
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",SIRPB1,Signal-regulatory protein beta-1,18400,102,1.88 [1.32-2.69],0.0004811104670824
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",SKAP2,Src kinase-associated phosphoprotein 2,18524,102,0.84 [0.71-0.99],0.0424685500883418
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",SLAMF6,SLAM family member 6,18045,99,2.63 [1.85-3.73],5.773176416239714e-08
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",SLAMF8,SLAM family member 8,18045,99,2.97 [2.20-4.01],1.272021869016389e-12
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",SLITRK2,SLIT and NTRK-like protein 2,18638,102,1.77 [1.16-2.70],0.0081647120188122
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",SMPD1,Sphingomyelin phosphodiesterase,18537,104,1.41 [1.02-1.94],0.035035513256136
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",SNAPIN,SNARE-associated protein Snapin,16010,87,0.64 [0.44-0.93],0.0201020354213681
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",SORCS2,VPS10 domain-containing receptor SorCS2,18045,99,2.03 [1.25-3.28],0.0041744166195068
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",SOX2,Transcription factor SOX-2,15972,87,1.96 [1.04-3.67],0.0367065017121189
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",SPON1,Spondin-1,18464,102,1.81 [1.10-2.98],0.0205622820345392
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,18442,100,0.77 [0.66-0.90],0.0009156713818013
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",STC1,Stanniocalcin-1,18630,104,1.80 [1.28-2.54],0.0006814848687991
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",SWAP70,Switch-associated protein 70,15981,89,1.73 [1.20-2.49],0.0035649644907066
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",TCN1,Transcobalamin-1,15739,89,1.54 [1.06-2.25],0.0249106670585607
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",TCOF1,Treacle protein,16035,90,2.23 [1.55-3.20],1.3784963549417972e-05
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",TFPI2,Tissue factor pathway inhibitor 2,18453,102,1.49 [1.13-1.95],0.0042867876533577
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",TGFBR1,TGF-beta receptor type-1,15553,86,2.14 [1.26-3.62],0.0047504042657202
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",TGFBR2,TGF-beta receptor type-2,18507,102,1.65 [1.04-2.64],0.0348736808115499
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",THY1,Thy-1 membrane glycoprotein,18630,104,2.24 [1.26-3.96],0.0056532197160848
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",TIE1,Tyrosine-protein kinase receptor Tie-1,18693,102,1.85 [1.09-3.15],0.023588186001339
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",TIGAR,"Fructose-2,6-bisphosphatase TIGAR",18040,99,1.43 [1.02-2.00],0.0389711236154513
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",TIGIT,T-cell immunoreceptor with Ig and ITIM domains,15752,83,1.78 [1.43-2.22],3.5058751948724053e-07
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,18552,101,1.74 [1.17-2.59],0.0061626719833744
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",TINAGL1,Tubulointerstitial nephritis antigen-like,18413,100,2.65 [1.21-5.82],0.0147422697394538
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",TK1,"Thymidine kinase, cytosolic",15752,83,1.46 [1.02-2.08],0.0373994260090512
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",TMED10,Transmembrane emp24 domain-containing protein 10,15510,86,0.45 [0.21-0.96],0.0400668444177332
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",TNC,Tenascin,18552,101,1.81 [1.28-2.56],0.0007549939639226
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",TNF,Tumor necrosis factor,18110,96,1.89 [1.49-2.40],2.074319240847075e-07
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,18313,100,1.86 [1.25-2.78],0.0022716628951033
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,18313,100,1.42 [1.17-1.72],0.0003109855682154
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,18685,103,1.80 [1.20-2.70],0.0042749951932505
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,18464,102,3.82 [2.97-4.90],5.700142223337349e-26
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,18156,100,3.23 [2.50-4.18],2.2681572004535015e-19
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",TNFRSF14,Tumor necrosis factor receptor superfamily member 14,18464,102,1.94 [1.16-3.25],0.0120266259836669
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",TNFRSF17,Tumor necrosis factor receptor superfamily member 17,15684,89,2.24 [1.38-3.64],0.0011370955832308
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",TNFRSF19,Tumor necrosis factor receptor superfamily member 19,18638,102,2.12 [1.34-3.34],0.0012240592539603
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,18464,102,1.92 [1.15-3.21],0.0120969102247363
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,18464,102,1.75 [1.37-2.24],9.423490448855376e-06
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",TNFRSF4,Tumor necrosis factor receptor superfamily member 4,18652,103,5.04 [3.67-6.93],1.5688423433045198e-23
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,18313,100,1.64 [1.28-2.10],0.0001091046188376
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",TNFRSF8,Tumor necrosis factor receptor superfamily member 8,18630,104,3.16 [2.45-4.07],5.592509613931561e-19
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",TNFRSF9,Tumor necrosis factor receptor superfamily member 9,18313,100,3.17 [2.61-3.86],5.751431780662511e-31
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",TNFSF8,Tumor necrosis factor ligand superfamily member 8,16044,90,2.85 [1.91-4.26],3.05998882770844e-07
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",TP53BP1,TP53-binding protein 1,15553,86,1.29 [1.03-1.62],0.0248519645460221
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",TP73,Tumor protein p73,15620,81,2.00 [1.08-3.70],0.027037642580632
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",TPPP3,Tubulin polymerization-promoting protein family member 3,18068,99,0.54 [0.31-0.95],0.0315241015822612
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",TRIM26,Tripartite motif-containing protein 26,15476,83,0.60 [0.37-0.96],0.0328487129923718
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",15553,86,1.68 [1.19-2.37],0.0033782251218481
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",ULBP2,UL16-binding protein 2,18313,100,1.65 [1.08-2.53],0.0206772772291141
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",VCAM1,Vascular cell adhesion protein 1,18529,100,4.29 [2.45-7.49],3.336535427987563e-07
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",VCAN,Versican core protein,18630,104,1.87 [1.07-3.26],0.0274020674201115
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",VNN1,Pantetheinase,16055,90,0.77 [0.59-1.00],0.0470164985031629
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",VSIG2,V-set and immunoglobulin domain-containing protein 2,15978,90,1.46 [1.12-1.90],0.0047581128155803
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",VSIG4,V-set and immunoglobulin domain-containing protein 4,18442,102,1.75 [1.18-2.60],0.005597793737184
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",WARS,"Tryptophan--tRNA ligase, cytoplasmic",18464,102,1.80 [1.14-2.82],0.0108756789898881
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",WFDC2,WAP four-disulfide core domain protein 2,17533,99,1.95 [1.35-2.82],0.0003562745791365
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",XCL1,Lymphotactin,18638,102,1.41 [1.08-1.85],0.0120601489552969
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",YAP1,Transcriptional coactivator YAP1,16004,88,2.22 [1.28-3.86],0.0045135783596975
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",ZBP1,Z-DNA-binding protein 1,15553,86,1.71 [1.19-2.47],0.0040292103013155
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",ZBTB17,Zinc finger and BTB domain-containing protein 17,18135,96,1.66 [1.27-2.18],0.0002542673253946
Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",ZHX2,Zinc fingers and homeoboxes protein 2,16004,88,1.51 [1.03-2.24],0.0370652419210537
